Andres Lazaro-Louloudes
Valdeolmos, MD 28130, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Heterologous DNA-Adenovirus Prime-Boost Strategy Expressing Bluetongue Virus VP2 and VP7 Proteins Protects Against Virulent Challenge.
Journal: Vaccines
Published: August 24, 2025
Bivalent SARS-CoV-2 spike immunization with non-replicative antibiotic resistance-free DNA vaccine induces immunity to multiple virus variants.
Journal: Scientific reports
Published: May 05, 2025
Double-stranded RNA orbivirus disrupts the DNA-sensing cGAS-sting axis to prevent type I IFN induction.
Journal: Cellular and molecular life sciences : CMLS
Published: April 21, 2024
Comprehensive immune profiling reveals that Orbivirus infection activates immune checkpoints during acute T cell immunosuppression.
Journal: Frontiers in immunology
Published: July 09, 2023
Non-replicative antibiotic resistance-free DNA vaccine encoding S and N proteins induces full protection in mice against SARS-CoV-2.
Journal: Frontiers in immunology
Published: September 02, 2022
Adenoviral delivery of soluble ovine OX40L or CD70 costimulatory molecules improves adaptive immune responses to a model antigen in sheep.
Journal: Frontiers in cellular and infection microbiology
Published: August 03, 2022
The Interplay between Bluetongue Virus Infections and Adaptive Immunity.
Journal: Viruses
Published: June 05, 2021
Targeting host metabolism by inhibition of acetyl-Coenzyme A carboxylase reduces flavivirus infection in mouse models.
Journal: Emerging microbes & infections
Published: April 20, 2019
Showing 1-8 of 8
Last Updated: 09/26/2026